Trial Profile

A prospective, randomized, controlled clinical study on the assessment of tolerance and clinical equivalence of hCG [human chorionic gonadotropin]-IBSA (IBSA) versus Ovitrelle (Serono) [choriogonadotropin alfa], both administered sub-cutaneously in women undergoing in vitro fertilization (IVF).

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Feb 2013 Results published in Gynecological Endocrinology.
01 Jun 2011 Biomarkers information updated
18 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com